NCT06999434View on ClinicalTrials.gov

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

PHASE1RecruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

May 5, 2030

Study Completion Date

May 5, 2030

Conditions
Demyelinating DisordersMCIAlzheimer's Disease (AD)MS (Multiple Sclerosis)SCI - Spinal Cord InjurySpinal Radiculopathy
Interventions
DRUG

[ 18F]3F4AP

PET Scan #3

DRUG

[18F]MK6240

PET Scan #2

DRUG

[11C]PIB

PET Scan #1

Trial Locations (1)

06510

RECRUITING

Yale University PET Center, New Haven

All Listed Sponsors
collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

Yale University

OTHER